|
Q4 2023
|
84 |
588,351 |
AAPL, ISRG, MA, NVDA
|
13F-HR
|
2/12/2024 |
000145517624000002 |
|
Q3 2023
|
78 |
530,868 |
AAPL, ISRG, MA, NVDA
|
13F-HR
|
11/9/2023 |
000145517623000009 |
|
Q2 2023
|
75 |
541,008 |
AAPL, ISRG, MA, NVDA
|
13F-HR
|
8/11/2023 |
000145517623000007 |
|
Q1 2023
|
76 |
494,598 |
AAPL, ISRG, MA, IDXX
|
13F-HR
|
5/9/2023 |
000145517623000005 |
|
Q4 2022
|
73 |
448,918 |
ISRG, AAPL, MA, IDXX
|
13F-HR
|
2/9/2023 |
000145517623000002 |
|
Q3 2022
|
74 |
433,679 |
AAPL, ISRG, MA, ABMD
|
13F-HR
|
11/7/2022 |
000145517622000009 |
|
Q2 2022
|
76 |
454,175 |
AAPL, ISRG, MA, GOOGL
|
13F-HR
|
8/11/2022 |
000145517622000007 |
|
Q1 2022
|
79 |
567,554 |
AAPL, ISRG, MA, GOOGL
|
13F-HR
|
5/12/2022 |
000145517622000005 |
|
Q4 2021
|
82 |
600,054 |
AAPL, ISRG, IDXX, GOOGL
|
13F-HR
|
2/8/2022 |
000145517622000002 |
|
Q3 2021
|
85 |
582,647 |
ISRG, AAPL, IDXX, ABMD
|
13F-HR
|
11/9/2021 |
000145517621000009 |
|
Q2 2021
|
85 |
582,117 |
ISRG, AAPL, IDXX, MA
|
13F-HR
|
8/3/2021 |
000145517621000007 |
|
Q1 2021
|
81 |
502,131 |
AAPL, ISRG, MA, ABMD
|
13F-HR
|
5/11/2021 |
000145517621000005 |
|
Q4 2020
|
85 |
521,831 |
AAPL, ISRG, MA, SQ
|
13F-HR
|
2/4/2021 |
000145517621000002 |
|
Q3 2020
|
83 |
461,247 |
AAPL, ISRG, SQ, MA
|
13F-HR
|
11/5/2020 |
000145517620000010 |
|
Q2 2020
|
77 |
396,066 |
AAPL, ISRG, MA, ABMD
|
13F-HR
|
8/7/2020 |
000145517620000008 |
|
Q1 2020
|
70 |
301,826 |
ISRG, AAPL, MA, VRTX
|
13F-HR
|
5/8/2020 |
000145517620000006 |
|
Q4 2019
|
87 |
433,380 |
ISRG, AAPL, MA, RETA
|
13F-HR
|
2/6/2020 |
000145517620000003 |
|
Q3 2019
|
86 |
391,268 |
ISRG, MA, AAPL, ILMN
|
13F-HR
|
11/5/2019 |
000145517619000008 |
|
Q2 2019
|
88 |
421,784 |
MA, ISRG, AAPL, EXAS
|
13F-HR
|
8/6/2019 |
000145517619000006 |
|
Q1 2019
|
81 |
398,608 |
ISRG, MA, AAPL, ABMD
|
13F-HR
|
5/8/2019 |
000145517619000004 |
|
Q4 2018
|
79 |
331,263 |
ISRG, MA, ABMD, AAPL
|
13F-HR
|
2/8/2019 |
000145517619000002 |
|
Q3 2018
|
80 |
421,050 |
ISRG, MA, AAPL, ABMD
|
13F-HR
|
11/7/2018 |
000145517618000008 |
|
Q2 2018
|
81 |
396,535 |
ISRG, MA, ABMD, AAPL
|
13F-HR
|
8/2/2018 |
000145517618000006 |
|
Q1 2018
|
88 |
383,876 |
MA, ISRG, AAPL, ABMD
|
13F-HR
|
5/2/2018 |
000145517618000004 |
|
Q4 2017
|
96 |
395,812 |
MA, ISRG, AAPL, META
|
13F-HR
|
2/7/2018 |
000145517618000002 |
|
Q3 2017
|
93 |
363,570 |
ISRG, MA, AAPL, CELG
|
13F-HR
|
11/8/2017 |
000145517617000008 |
|
Q2 2017
|
79 |
345,754 |
ISRG, MA, AAPL, CELG
|
13F-HR
|
8/11/2017 |
000145517617000006 |
|
Q1 2017
|
76 |
279,934 |
ISRG, MA, CELG, JPMORGAN CHASE & CO
|
13F-HR
|
5/1/2017 |
000145517617000004 |
|
Q4 2016
|
75 |
302,364 |
MA, ISRG, CELG, BAC+A
|
13F-HR
|
2/6/2017 |
000145517617000002 |
|
Q3 2016
|
77 |
295,620 |
ISRG, MA, AAPL, CELG
|
13F-HR
|
11/3/2016 |
000145517616000017 |
|
Q2 2016
|
76 |
280,248 |
ISRG, MA, CELG, JPMORGAN CHASE & CO
|
13F-HR
|
7/21/2016 |
000145517616000015 |
|
Q1 2016
|
73 |
263,808 |
MA, ISRG, CELG, META
|
13F-HR
|
5/9/2016 |
000145517616000013 |
|
Q4 2015
|
79 |
301,467 |
CELG, MA, PCRX, ISRG
|
13F-HR
|
1/29/2016 |
000145517616000012 |
|
Q3 2015
|
82 |
300,793 |
CELG, MA, AAPL, GILD
|
13F-HR
|
11/10/2015 |
000145517615000010 |
|
Q2 2015
|
85 |
333,203 |
CELG, MA, GILD, AAPL
|
13F-HR
|
7/23/2015 |
000145517615000008 |
|
Q1 2015
|
81 |
337,212 |
PCRX, CELG, MA, AAPL
|
13F-HR
|
5/5/2015 |
000145517615000005 |
|
Q4 2014
|
84 |
332,473 |
PCRX, CELG, MA, JPMORGAN CHASE AND CO
|
13F-HR
|
1/5/2015 |
000145517615000003 |
|
Q3 2014
|
85 |
325,491 |
PCRX, CELG, GILD, MA
|
13F-HR
|
10/6/2014 |
000145517614000006 |
|
Q2 2014
|
91 |
317,137 |
PCRX, CELG, JPMORGAN CHASE AND CO, MA
|
13F-HR
|
7/8/2014 |
000145517614000004 |
|
Q1 2014
|
93 |
301,737 |
JPMORGAN CHASE AND CO, PCRX, MA, F
|
13F-HR
|
4/3/2014 |
000145517614000003 |
|
Q4 2013
|
98 |
292,846 |
MA, CELG, JPMORGAN CHASE AND CO, F
|
13F-HR
|
1/9/2014 |
000145517614000002 |